Cargando…
COVID-19 Vaccine Triggered Rejection in Lung Transplant Recipients: A Case Series
PURPOSE: Anti-severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) vaccination is recommended by AST, ISHLT, and CDC in all transplant recipients. Lung transplant recipients (LTR) are at a higher risk of developing severe symptoms due to higher immunosuppression (IS) and baseline compromise...
Autores principales: | Alsunaid, S., Caputo, V., Stryker, K., Diouf, J., Abbasi, M., Borgi, J., Forest, S., Mansour, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988696/ http://dx.doi.org/10.1016/j.healun.2022.01.1352 |
Ejemplares similares
-
The United States Experience of Lung Transplantation in Recipients with COVID-19 Fibrosis: A UNOS/OPTN Analysis
por: Phan, D.K., et al.
Publicado: (2022) -
Efficacy and safety of the SARS-CoV-2 mRNA vaccine in lung transplant recipients: a possible trigger of rejection
por: Goda, Yasufumi, et al.
Publicado: (2022) -
The Airway Microbiota Signatures of Infection and Rejection in Lung Transplant Recipients
por: Su, Jin, et al.
Publicado: (2022) -
Metronomic capecitabine inhibits liver transplant rejection in rats by triggering recipients’ T cell ferroptosis
por: Wang, Hao, et al.
Publicado: (2023) -
Assessment of Carfilzomib Treatment Response in Lung Transplant Recipients With Antibody-mediated Rejection
por: Pham, Christine, et al.
Publicado: (2021)